Atherectomy Devices Market Analysis
The Global Atherectomy Devices Market will reach US$ 2,028.3 Million by 2032, up from US$ 964.3 Million in 2023, with a CAGR of 8.61% between 2024 and 2032. The emergence of minimally invasive surgeries, the development of healthcare infrastructure, the rise in peripheral artery disease (PAD), notable technological advancements, the aging population, and reimbursement policies in emerging economies are some of the major factors propelling the atherectomy market.
Atherectomy Devices Industry Overview
Atherectomy devices are medical instruments used to remove plaque from blood vessels. These devices are commonly employed in the treatment of arterial blockages, particularly in the coronary and peripheral arteries. Atherectomy is a minimally invasive procedure that helps improve blood flow and reduce the risk of serious complications such as heart attacks and strokes.
Request a free sample copy of the report: https://www.renub.com/atherectomy-devices-market-p.php
The global use of atherectomy devices has been instrumental in addressing various cardiovascular conditions. These devices are widely utilized by healthcare professionals to treat patients with peripheral artery disease (PAD), coronary artery disease, and other vascular disorders. The versatility and effectiveness of atherectomy devices have contributed to their widespread adoption across different regions, benefiting patients by offering a minimally invasive alternative to traditional surgical methods.
Atherectomy devices play a crucial role in enhancing patient outcomes and quality of life by providing a safe and efficient means of addressing arterial plaque buildup. As medical technology continues to advance, atherectomy devices are expected to play an increasingly significant role in the treatment of vascular diseases worldwide.
Growth Drivers of Atherectomy Devices Market
Rising Prevalence of Cardiovascular Diseases
The increasing incidence of cardiovascular diseases (CVDs), such as coronary artery disease (CAD) and peripheral artery disease (PAD), is a major growth driver for the atherectomy devices market. As lifestyle factors, including poor diet and lack of exercise, contribute to higher rates of CVDs, the demand for effective treatment options rises. Atherectomy devices, which are used to remove plaque buildup from arteries, play a crucial role in treating these conditions. The growing need for minimally invasive procedures to manage cardiovascular health boosts the adoption of atherectomy devices, driving market growth and encouraging innovation in device technology.
Advancements in Medical Technology
Technological advancements in atherectomy devices are significantly contributing to market growth. Innovations such as improved imaging techniques, enhanced device designs, and advanced materials have led to the development of more effective and safer atherectomy tools. These advancements enable precise plaque removal, reduced procedural complications, and faster recovery times for patients. The integration of technologies like intravascular ultrasound (IVUS) and optical coherence tomography (OCT) with atherectomy devices enhances their performance and efficacy. As technology continues to evolve, the market for atherectomy devices expands, driven by the demand for cutting-edge solutions in cardiovascular treatment.
Growing Preference for Minimally Invasive Procedures
The shift towards minimally invasive procedures is a key growth driver for the atherectomy devices market. Patients and healthcare providers increasingly favor less invasive options due to their benefits, including reduced recovery time, lower risk of complications, and shorter hospital stays. Atherectomy devices, which facilitate plaque removal with minimal incisions, align with this preference for minimally invasive techniques. The trend towards outpatient procedures and advancements in atherectomy technology contribute to the growing adoption of these devices. As the healthcare industry continues to prioritize patient-centric approaches and efficient treatments, the demand for minimally invasive atherectomy procedures drives market growth.
Europe Atherectomy Devices Market
The Europe Atherectomy Devices Market refers to the market for medical devices used for atherectomy procedures in European countries. Atherectomy is a minimally invasive procedure to remove atherosclerosis from blood vessels. The market for atherectomy devices in Europe is driven by factors such as the increasing incidence of peripheral artery disease (PAD) and the growing elderly population. The market includes various types of atherectomy devices such as rotational atherectomy devices, orbital atherectomy devices, directional atherectomy devices, and laser atherectomy devices. Key market players, technological advancements, and regulatory factors also play a significant role in shaping the landscape of the Europe Atherectomy Devices Market.
Atherectomy Devices Company Analysis
The leading companies in the atherectomy devices market are AngioDynamics Inc., Terumo Corporation, Integer Holdings Corporation, Boston Scientific Corporation, Inc., Abbott Laboratories, Medtronic plc, Cardinal Health, and Becton, Dickinson and Company.
Atherectomy Devices Company News
In November 2023, Cardinal Health announced the debut of their SmartGown EDGE Breathable Surgical Gown with ASSIST Instrument Pockets in the United States to provide surgical teams with safe and useful instrument access in the operating room.
In June 2023, The FDA has approved Pantheris LV, a next-generation image-guided atherectomy device developed by Avinger, Inc. to treat peripheral artery disease (PAD). The system has new features such improved torque feedback, plaque apposition design, and faster cutter rates. By the end of the quarter, it will be introduced in restricted quantities, and in the second half of 2023, it will be made fully available for purchase. With no ionizing radiation exposure, treatment is guided by optical coherence tomography (OCT) pictures with Avinger's Lumivascular technology, guaranteeing safe and successful results.
In February 2023, Cardiovascular Systems, a well-known manufacturer of medical devices noted for its innovative atherectomy system intended to treat peripheral and coronary artery disease, was purchased by Abbott. A monetary payment of $20 per common share will be given to CSI investors as per the terms of the agreement; this will raise the expected equity value to $890 million. Regarding atherectomy devices, CSI is one of the leading companies in the business. These tools are intended to maximize the benefits of conventional balloon angioplasty and stent therapies, especially when complex vascular disorders are involved. Abbott's portfolio of vascular devices will be improved by the acquisition by adding complementary technology.
Related Report:
Global 4K Medical Imaging Market: https://www.renub.com/4k-medical-imaging-market-p.php
Trauma Fixation Device Market: https://www.renub.com/worldwide-trauma-fixation-device-market-and-forecast-519-p.php
Embolic Protection Device Market: https://www.renub.com/embolic-protection-device-market-p.php
Product Type– Market breakup in 4 viewpoints:
- Directional Atherectomy
- Rotational Atherectomy
- Orbital Atherectomy
- Laser Atherectomy
Application– Market breakup in 3 viewpoints:
- Cardiovascular
- Neurovascular
- Peripheral Vascular
End User– Market breakup in 3 viewpoints:
- Hospitals
- Ambulatory Care Service
- Medical Research Institutes
Countries– Market breakup in 26 viewpoints:
- North America
- United States
- Canada
- Europe
- France
- Germany
- Italy
- Spain
- United Kingdom
- Belgium
- Netherland
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
- Malaysia
- Indonesia
- New Zealand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East Africa
- South Africa
- Saudi Arabia
- Turkey
- UAE
- Rest of the World
All the key players have been covered from 4 Viewpoints:
- Business Overview
- Key Persons
- Recent Development Strategies
- Financial Insights
Key Players Analysis:
- Boston Scientific Corporation, Inc.
- Abbott Laboratories
- Medtronic plc
- Cardinal Health
- Terumo Corporation
- Integer Holdings Corporation
- Becton, Dickinson and Company
- AngioDynamics Inc.
Key Questions Answered in This Report:
- How big is the Atherectomy Devices industry?
- What is the Atherectomy Devices industry growth rate?
- Who are the key players in Atherectomy Devices industry?
- What are the factors driving the Atherectomy Devices industry?
- Which Region held the largest market share in the Atherectomy Devices industry?
- What segments are covered in the Atherectomy Devices Market report?
About the Company:
Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers acquisitions, etc. Till now we have published more than 9000 syndicated reports and worked on more than 750 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076
Email: info@renub.com
LinkedIn: https://linkedin.com/company/renub-research
Website: www.renub.com